Sfoglia per Rivista  DIABETES, OBESITY AND METABOLISM

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 1 a 15 di 15
Titolo Data di pubblicazione Autore(i) File
Alogliptin as a Third Oral Antidiabetic Drug in Patients With Type 2 Diabetes and Inadequate Glycemic Control on Metformin and Pioglitazone: A 52-Week, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study 1-gen-2011 Bosi, Emanuele; Ellis, Gc; Wilson, Ca; Fleck, P. R.
Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin 1-gen-2011 Ahrén, B; Foley, Je; Bosi, Emanuele
Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week double-blind, randomized trial 1-gen-2009 Schweizer, A; Dejager, S; Bosi, Emanuele
Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial 1-gen-2012 Monti, Ld; Setola, E; Lucotti, Pc; Marrocco Trischitta, Mm; Comola, M; Galluccio, E; Poggi, A; Mammì, S; Catapano, Al; Comi, G; Chiesa, Roberto; Bosi, Emanuele; Piatti, Pm
Effectiveness of a closed-loop control system and a virtual educational camp for children and adolescents with type 1 diabetes: A prospective, multicentre, real-life study 1-gen-2021 Cherubini, V.; Rabbone, I.; Berioli, M. G.; Giorda, S.; Lo Presti, D.; Maltoni, G.; Mameli, C.; Marigliano, M.; Marino, M.; Minuto, N.; Mozzillo, E.; Piccinno, E.; Predieri, B.; Ripoli, C.; Schiaffini, R.; Rigamonti, A.; Salzano, G.; Tinti, D.; Toni, S.; Zanfardino, A.; Scaramuzza, A. E.; Gesuita, R.; Tiberi, V.; Savastio, S.; Pigniatiello, C.; Trada, M.; Zucchini, S.; Redaelli, F. C.; Maffeis, C.; Bassi, M.; Rosanio, F. M.; Delvecchio, M.; Buzzi, P.; Ricciardi, M. R.; Carducci, C.; Bonfanti, R.; Lombardo, F.; Piccini, B.; Iafusco, D.; Calandretti, M.; Daga, F. A.
The Effects of Kisspeptin on β-cell Function, Serum Metabolites and Appetite in Humans 1-gen-2018 Izzi-Engbeaya, Chioma; Comninos, Alexander N; Clarke, Sophie A; Jomard, Anne; Yang, Lisa; Jones, Sophie; Abbara, Ali; Narayanaswamy, Shakunthala; Eng, Pei Chia; Papadopoulou, Debbie; Prague, Julia K; Bech, Paul; Godsland, Ian F; Bassett, Paul; Sands, Caroline; Camuzeaux, Stephane; Gomez Romero, Maria; Pearce, Jake T M; Lewis, Matthew R; Holmes, Elaine; Nicholson, Jeremy K; Tan, Tricia; Ratnasabapathy, Risheka; Hu, Ming; Carrat, Gaelle; Piemonti, Lorenzo; Bugliani, Marco; Marchetti, Piero; Johnson, Paul R; Hughes, Stephen J; Shapiro, A M James; Rutter, Guy A; Dhillo, Waljit S
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial 1-gen-2019 Ruggenenti, P.; Trillini, M.; P. Barlovic, D.; Cortinovis, M.; Pisani, A.; Parvanova, A.; Iliev, I. P.; Ruggiero, B.; Rota, S.; Aparicio, M. C.; Perna, A.; Peraro, F.; Diadei, O.; Gaspari, F.; Carrara, F.; Stucchi, N.; Martinetti, D.; Janez, A.; Gregoric, N.; Riccio, E.; Bossi, A. C.; Trevisan, R.; Manunta, P.; Battaglia, G.; David, S.; Aucella, F.; Belviso, A.; Satta, A.; Remuzzi, G.
From antibodies to adiponectin: role of ERp44 in sizing and timing protein secretion 1-gen-2010 Cortini, M; Sitia, Roberto
Implementing Control-IQ technology after a virtual educational camp in children and adolescents with type 1 diabetes: Does time in range plateau over 1 year? 1-gen-2023 Scaramuzza, A. E.; Marigliano, M.; Bonfanti, R.; Cherubini, V.; Schiaffini, R.; Toni, S.; Rabbone, I.
In vivo and in vitro characterisation of GL0034, a novel long-acting GLP-1 receptor agonist 1-gen-2022 Jones, Ben; Burade, Vinod; Akalestou, Elina; Manchanda, Yusman; Ramchunder, Zenouska; Carrat, Gaëlle; Nguyen-Tu, Marie-Sophie; Marchetti, Piero; Piemonti, Lorenzo; Leclerc, Isabelle; Rajamannar, Thennati; Vilsboll, Tina; Thorens, Bernard; Tomas, Alejandra; Rutter, Guy A
Insulin pump breakdown and infusion set failure in Italian children with type 1 diabetes: A 1-year prospective observational study with suggestions to minimize clinical impact 1-gen-2018 Rabbone, I.; Minuto, N.; Toni, S.; Lombardo, F.; Iafusco, D.; Marigliano, M.; Schiaffini, R.; Maltoni, G.; Frongia, A. P.; Scardapane, M.; Nicolucci, A.; Cherubini, V.; Bonfanti, R.; Scaramuzza, A. E.
Ladarixin, an inhibitor of IL-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: a multicenter, randomized, double-blind, placebo-controlled trial 1-gen-2022 Piemonti, Lorenzo; Keymeulen, Bart; Gillard, Pieter; Linn, Thomas; Bosi, Emanuele; Rose, Ludger; Pozzilli, Paolo; Giorgino, Francesco; Cossu, Efisio; Daffonchio, Luisa; Goisis, Giovanni; Ruffini, Pier Adelchi; Maurizi, Anna Rita; Mantelli, Flavio; Allegretti, Marcello
Metformin--the gold standard in type 2 diabetes: what does the evidence tell us? 1-gen-2009 Bosi, Emanuele
Retrospective analysis of 24-month real-world glucose control for children and adolescents with type 1 diabetes using the MiniMedTM 670G insulin pump 1-gen-2022 Delvecchio, Maurizio; Galati, Alessio; Maffeis, Claudio; Passanisi, Stefano; Bonfanti, Riccardo; Franceschi, Roberto; Tornese, Gianluca; Calzi, Elena; Zanfardino, Angela; Bracciolini, Giulia Patrizia; Piccinno, Elvira
Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naïve patients with type 2 diabetes mellitus 1-gen-2009 Bosi, Emanuele; Dotta, F; Jia, Y; Goodman, M.
Mostrati risultati da 1 a 15 di 15
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile